Make your money go further for just 25p per day

AIM IHT

Hidden value | Questionable cash flow

Adaptix home page image

Updates from AIM covered here include the realisation of some hidden value in an engineering group, where a small investment could pay off handsomely. Elsewhere, we are puzzled with the cash flow of two other companies covered here.


Avingtrans highlights its hidden value

Avingtrans (AIM: AVG), which manufactures critical components, to the energy, medical and industrial sectors, has made an announcement which serves to highlight some hidden value in its operations.

A company in which it has a minority investment, called Adaptix, has received 510(k) clearance from the U.S. Food and Drug Administration for its first orthopaedic medical imaging product.

In 2021, Avingtrans invested £4m in Adaptix, for an 11.9% stake in…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Avingtrans PLC

Episode 7 of the Investor’s Champion Podcast

02/03/2024 · Podcasts

In this episode of the Investor’s Champion Podcast Chris and Lee run through key stock market…


Utter gobbledygook | Tough to value

29/02/2024 · Company Insights

Results from a well-known wealth manager covered here are as confusing as their fees and we…


More on Inspired Energy PLC

Another AIM company receives an offer

11/09/2023 · Company Insights

The week kicks-off with yet another offer for a modestly valued AIM company. We remain puzzled why…


Hidden value | Questionable cash flow

30/01/2023 · Company Insights

Updates from AIM covered here include the realisation of some hidden value in an engineering group, where…


More on Sopheon

Whopping contract | FDA approval | Another offer

02/11/2023 · Company Insights

Our free update here includes news of yet another significant contract win for a high-performing AIM…


Hidden value | Questionable cash flow

30/01/2023 · Company Insights

Updates from AIM covered here include the realisation of some hidden value in an engineering group, where…


More Company Insights

Bonkers Bargains: terrific growth and still a bargain

02/10/2024 · Time Finance

50 years of growing dividends | Transformational deals worry us

Sign-up to our free email updates

SIGN UP